Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
22.7M
-
Shares change
-
-105K
-
Total reported value, excl. options
-
$139M
-
Value change
-
-$504K
-
Put/Call ratio
-
0.01
-
Number of buys
-
31
-
Number of sells
-
-28
-
Price
-
$6.10
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2022
82 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q4 2022.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.7M shares
of 55.2M outstanding shares and own 41.22% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (5.43M shares), EcoR1 Capital, LLC (4.75M shares), ARMISTICE CAPITAL, LLC (3.4M shares), VANGUARD GROUP INC (1.96M shares), Erste Asset Management GmbH (1.14M shares), BlackRock Inc. (843K shares), PRICE T ROWE ASSOCIATES INC /MD/ (797K shares), D. E. Shaw & Co., Inc. (689K shares), ACADIAN ASSET MANAGEMENT LLC (669K shares), and FEDERATED HERMES, INC. (606K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.